Anuh Pharma Ltd.
| BSE: 506260 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE489G01022 |
| BSE 00:00 | 25 May | 96.85 |
1.35 (1.41%) |
OPEN
95.50 |
HIGH
97.00 |
LOW
93.25 |
| NSE 05:30 | 01 Jan | Anuh Pharma Ltd Not listed in NSE |
| OPEN | 95.50 |
| PREVIOUS CLOSE | 95.50 |
| VOLUME | 24133 |
| 52-Week high | 154.90 |
| 52-Week low | 84.60 |
| P/E | 15.88 |
| Mkt Cap.(Rs cr) | 485 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Anuh Pharma Ltd.
Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company offers bulk drugs and chemicals. Their products are antibiotics erythromycin salts chloramphenicol and other chemicals. The company is part of the SK Group.Anuh Pharma Ltd was incorporated on February 19 1960. The company is well positioned to service their existing and potential markets th...> More
Anuh Pharma Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
485 | |
| EPS - TTM | () |
[*S] | 6.10 |
| P/E Ratio | (X) | [*S] | 15.88 |
| Face Value | () |
5 | |
| Latest Dividend | (%) | 30.00 | |
| Latest Dividend Date | 17 Aug 2021 | ||
| Dividend Yield | (%) | 1.83 | |
| Book Value / Share | () |
[*S] | 42.66 |
| P/B Ratio | () |
[*S] | 2.27 |
Announcement
-
Revised Submission Of Audited Financial Results Along With Auditors Report For The Year Ended March
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regu
-
Submission Of Audited Financial Results Along With Auditors Report For The Year Ended March 31 2022
Anuh Pharma Ltd - Financial Results
Particulars ( cr) |
Mar 2022 | Mar 2021 | % Chg |
| Net Sales | 128.97 | 97.15 | 32.75 |
| Other Income | 1.03 | 1.56 | -33.97 |
| Total Income | 130 | 98.71 | 31.7 |
| Total Expenses | 115.1 | 93.08 | 23.66 |
| Operating Profit | 14.9 | 5.62 | 165.12 |
| Net Profit | 8.93 | 0.9 | 892.22 |
| Equity Capital | 25.06 | 25.06 | - |
Anuh Pharma Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Nectar Lifesci. | 24.55 | -3.35 | 550.66 |
| Lincoln Pharma. | 264.35 | -5.67 | 529.49 |
| Windlas Biotech | 223.30 | 0.00 | 486.79 |
| Anuh Pharma | 96.85 | 1.41 | 485.41 |
| Kwality Pharma | 424.45 | 1.76 | 440.58 |
| Zim Laboratories | 245.55 | 4.73 | 398.77 |
| Fredun Pharma | 851.10 | -3.93 | 377.04 |
Anuh Pharma Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherAnuh Pharma Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -2.07% | NA | -0.85% | -1.32% |
| 1 Month | -1.48% | NA | -5.00% | -5.47% |
| 3 Month | -0.51% | NA | -3.78% | -3.80% |
| 6 Month | -7.67% | NA | -8.58% | -8.61% |
| 1 Year | -31.43% | NA | 6.15% | 5.37% |
| 3 Year | 40.20% | NA | 36.30% | 35.31% |
Anuh Pharma Ltd - STOCK STRENGTH
| Today's Low/High | 93.25 |
|
97.00 |
| Week Low/High | 93.25 |
|
103.00 |
| Month Low/High | 88.00 |
|
103.00 |
| YEAR Low/High | 84.60 |
|
155.00 |
| All TIME Low/High | 0.14 |
|
219.00 |
Quick Links for Anuh Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
